Results 71 to 80 of about 35,140 (296)

The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample [PDF]

, 2008
Background. Oncogenetic counselling is seldom followed through, even when individuals are eligible according to the test criteria. The basic variables which influence the decision to undergo the genetic counselling process are: risk perception, expected ...
Anita Caruso, Cristina Vigna, Gabriella Maggi, Fabio Massimo Sega, Francesco Cognetti, Antonella Savarese, JP Struewing, LG Bluman, C Lerman, KA Donovan, C Lerman, K Brain, JL Bottorff, I VanOostrom, M Bruno, K Glanz, KA Johnson, C Lerman, C Lerman, F Gil, K Kelly, AS Zigmond, M Costantini, DH Olson, C Galimberti, C Foster, MJ Esplen, R Kenen, DJ Bowen, D Braithwaite, SJ Durfy, AM Codori, C Lerman, IM Van Der Steenstraten, C Lerman, S Wiggins, C Lerman   +36 more
core   +2 more sources

Trastuzumab Deruxtecan for HER2‐Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
ABSTRACT Trastuzumab deruxtecan (T‐DXd) is a third‐generation, HER2‐targeting antibody‐drug conjugate that has been shown to significantly prolong overall survival, compared with standard chemotherapy, when used to treat patients who have “HER2‐low” (HER2 immunohistochemistry [IHC] score 1+; or HER2 IHC 2+ plus in situ hybridization‐negative ...
Andrew Redfern, Elgene Lim, Sunil Lakhani, Nirmala Pathmanathan, Sudarsha Selva‐Nayagam, Nicole McCarthy, Belinda Yeo, Benjamin Dessauvagie, Gelareh Farshid   +8 more
wiley   +1 more source

Adjustment to colostomy: stoma acceptance, stoma care self-efficacy and interpersonal relationships [PDF]

, 2007
‘The definitive version is available at www.blackwell-synergy.com.’ Copyright Blackwell Publishing. DOI: 10.1111/j.1365-2648.2007.04446.xThis paper is a report of a study to examine adjustment and its relationship with stoma acceptance and social ...
American Cancer Society, Arora N.K., Baxter A., Bekkers M.J.T.M., Brydolf M., Cazador C., Couper J.W., Diversey Lever, Felton E.A., Ferlay J., Field A., Friedman L.C., Giesse-Davis J., Gordon R., Gutterrez O., Hosmer D.W., IARC GLOBOCAN, ISD Online, Karadag A., Kerr J., Li L., Livneh H., Lutgendork S., Mallinger J., Mc Vey J., McGuire L., McKenzie F., Murray J., Olbrisch M.E., Piwonka A.M., Rashidian A., Smyth J., Soliani P., Sprangers M., White C.A.   +34 more
core   +1 more source

Management of Adult Patients With Isocitrate Dehydrogenase‐Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro‐Oncology

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Following maximal surgery when feasible, management of adult patients with isocitrate dehydrogenase (IDH)‐mutant glioma is complex and should be considered in a neuro‐oncology multidisciplinary context balancing disease control versus potential treatment‐associated toxicities. Options include continued surveillance, radiation therapy, chemotherapy, and/
Mark B. Pinkham, Hao‐Wen Sim, Rosalind L. Jeffree, Arian Lasocki, Dianne M. Legge, Frank Saran, Laveniya Satgunaseelan, Hui K. Gan   +7 more
wiley   +1 more source

Depressive symptoms in cancer patients compared with people from the general population: the role of sociodemographic and medical factors [PDF]

, 2003
This study examined depressive symptoms in 475 patients with cancer and in a reference group of 255 individuals without cancer from the general population and the associations of those symptoms with sociodemographic and medical factors.
Ranchor, A.V., Sanderman, R., Schroevers, M.J.   +2 more
core   +7 more sources

Stress levels during the journey of cancer treatment [PDF]

, 2017
A patient’s journey with cancer may cause psychological disorders or exacerbate existing conditions. The field of psycho-oncology has found ways to link psychological disorders to cancer and research the effects of mental disorders on patient outcome and
Ball, Patrick, Khan, Umer, Morrissey, Hana   +2 more
core  

Impact of Metformin and Diabetes on Tumor Response to Total Neoadjuvant Therapy in Advanced Rectal Cancer: A Multicenter Retrospective Cohort Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
In advanced rectal cancer patients receiving total neoadjuvant therapy (TNT), overall tumor response did not differ by diabetes status or metformin use. However, among diabetic patients, metformin use was associated with higher overall complete response rates. These findings suggest a potential benefit of metformin in enhancing TNT response in diabetic
Sergei Bedrikovetski, Mahima Raju, Tracy Fitzsimmons, Ishraq Murshed, Timothy J. Price, Michael Penniment, Sudarsha Selva‐Nayagam, Tarik Sammour   +7 more
wiley   +1 more source

Frontliners narratives: qualitative insights into EMDR group therapy during COVID-19

European Journal of Psychotraumatology
Background: The COVID-19 pandemic raised unprecedented challenges for frontline healthcare workers and emergency volunteers, leading to significant psychological distress.
Laura Torricelli, Ivanna Gasparini, Matias Eduardo Diaz Crescitelli, Silvia Filiberti, Laura Remondini, Luca Ghirotto, Elisa Rabitti, Giulia Rubini, Eleonora Zini, Silvia Di Leo   +9 more
doaj   +1 more source

Benefits and barriers of cancer practitioners discussing physical activity with their cancer patients [PDF]

, 2017
Our aim was to synthesise the existing empirical literature and theoretical perspectives on the physical activity (PA) promotion practices and determinants of cancer clinicians and health professionals.
Climstein, Michael, Jones, Lynnette, Keogh, Justin W L, Olsen, Alicia, Sargeant, Sally   +4 more
core   +1 more source

Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Extragonadal germ cell tumors (EGCTs) are rare, with limited prospective data to guide treatment or inform prognosis. Incidence and treatment patterns of EGCT in Australia reflect international data and practices. Compared to testicular primaries, the prognosis of EGCT is poor, especially for primary mediastinal non‐seminoma.
Kar Ven Cavan Chow, Ciara Conduit, Sophie O'Haire, Anna Kuchel, Shirley Wong, Peter Grimison, Andrew Weickhardt, Ganes Pranavan, James Lynam, Patricia Bastick, Jeffrey Goh, Shomik Sengupta, Annabel Smith, Elizabeth Liow, David Campbell, Ming Wong, Kristina Zlatic, Peter Gibbs, Ben Tran, Chun Loo Gan   +19 more
wiley   +1 more source